产品中心Products Resources
联系我们CONTACT US
-
400 179 0116
24小时服务热线
当前位置:首页 > 产品中心(Products) > 细胞定制Cell Customization(Cell Customization) > 稳转细胞株(Transfected Stable Cell Lines) > 示踪/报告细胞株(Report Transfection cell line) > GR-GAL4报告细胞系(Luc)-HEK293
产品描述/Products Description
The Glucocorticoid Receptor Pathway GAL4 Reporter (Luc) – HEK293 Cell Line contains a firefly luciferase gene under the control of glucocorticoid receptor ligand binding domain that is fused to the DNA binding domain (DBD) of GAL4 (GAL4 DBD-GR) stably integrated into HEK293 cells. This fusion construct activates firefly luciferase expression under the control of a multimerized GAL4 upstream activation sequence (UAS). This allows for specific detection of glucocorticoid-induced activation of the glucocorticoid receptor without the need for individual transcriptional targets and with low cross-reactivity for other nuclear receptor pathways. This cell line is validated for response to stimulation of DXMS and to the treatment with mifepristone, an inhibitor of the glucocorticoid signaling pathway.